Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rosuvastatin: winner in the statin wars, patients' health notwithstanding.

× No keyword cloud information.

7 in total

Review 1. Why maximum tolerated dose?

Authors: Hans G Stampfer; Genevieve M Gabb; Simon B Dimmitt
Journal: Br J Clin Pharmacol Date: 2019-07-22 Impact factor: 4.335

Review 2. The pharmacodynamic and clinical trial evidence for statin dose.

Authors: Simon B Dimmitt; Hans G Stampfer; John B Warren
Journal: Br J Clin Pharmacol Date: 2018-04-16 Impact factor: 4.335

3. Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria.

Authors: Jung-Im Shin; Derek M Fine; Yingying Sang; Aditya Surapaneni; Stephan C Dunning; Lesley A Inker; Thomas D Nolin; Alex R Chang; Morgan E Grams
Journal: J Am Soc Nephrol Date: 2022-07-19 Impact factor: 14.978

4. High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines.

Authors: Jaran Eriksen; Lars L Gustafsson; Kristina Ateva; Pia Bastholm-Rahmner; Marie-Louise Ovesjö; Malena Jirlow; Maria Juhasz-Haverinen; Gerd Lärfars; Rickard E Malmström; Björn Wettermark; Eva Andersén-Karlsson
Journal: BMJ Open Date: 2017-05-02 Impact factor: 2.692

Rosuvastatin: winner in the statin wars, patients' health notwithstanding.

Review 1. Why maximum tolerated dose?

Review 2. The pharmacodynamic and clinical trial evidence for statin dose.

3. Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria.

4. High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines.

5. Rosuvastatin-Induced Rhabdomyolysis: A Case Report.

6. Time trends in statin utilisation and coronary mortality in Western European countries.

7. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.